We found that anti-CD132 administration protected NOD mice from diabetes onset, hyperglycemia, and destructive insulitis compared with the isotype control group (Fig. 7b–d), with no difference in body weight (Supplementary Fig. S7a). Here, IL2RG is linked to Hyperglycemia.